Inventiva (IVA) Non-Current Assets (2018 - 2025)
Inventiva (IVA) recorded quarterly Non-Current Assets of $5.9 million in Q4 2025, down 99.92% quarter-over-quarter from $7.0 billion in Q2 2025, and down 26.34% on a YoY basis from $8.0 million in Q4 2024.
Inventiva (IVA) Non-Current Assets (2018 - 2025) Analysis & Trends
Inventiva's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.9 million for Q4 2025.
- In Q4 2025, Non-Current Assets fell 26.34% year-over-year to $5.9 million; the TTM figure through Dec 2025 stood at $5.9 million (down 26.34% YoY), while the FY2025 annual figure was $5.9 million, down 26.34% from the prior year.
- Non-Current Assets was $5.9 million for Q4 2025 at Inventiva, down from $7.0 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $9.0 billion in Q2 2022 to a low of $5.9 million in Q4 2025.
- Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $9.4 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 101451.95% in 2022, then slumped 65.35% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $7.3 million in 2021, then surged by 33.9% to $9.8 million in 2022, then soared by 134.25% to $23.0 million in 2023, then plunged by 65.35% to $8.0 million in 2024, then declined by 26.34% to $5.9 million in 2025.
- The last three Non-Current Assets figures came in at $5.9 million (Q4 2025), $7.0 billion (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 62,953.78 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 39.71 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 5.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.87 Mn |
| Jun 30, 2025 | 6.95 Bn |
| Dec 31, 2024 | 7.97 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Dec 31, 2023 | 22.99 Mn |
| Dec 31, 2022 | 9.82 Mn |
| Jun 30, 2022 | 9.03 Bn |
| Dec 31, 2021 | 7.33 Mn |
| Jun 30, 2021 | 8.89 Mn |
| Mar 31, 2021 | 8.21 Mn |
| Dec 31, 2020 | 7.06 Mn |
| Jun 30, 2020 | 9.42 Mn |
| Dec 31, 2019 | 8.95 Mn |
| Dec 31, 2018 | 9.33 Mn |